Changes in US stocks | Brain Regeneration Technology (RGC.US) rose more than 18% with a total market capitalization of more than US$4.8 billion

Zhitongcaijing · 05/14 14:57

The Zhitong Finance App learned that on Wednesday, the stock price of Brain Regeneration Technology (RGC.US) soared. As of press release, the stock had risen more than 18% to 370.43 US dollars. Currently, the stock's market value exceeds 4.8 billion US dollars. Brain Regeneration Technology is an early-stage biotechnology company focused on treating neurocognitive impairment and degenerative diseases with traditional Chinese medicine. The company was founded on October 30, 2014, and is registered in the Cayman Islands. It mainly operates through its subsidiary in Hong Kong.